ZARBO, Ignazio Roberto
 Distribuzione geografica
Continente #
NA - Nord America 615
EU - Europa 288
AS - Asia 122
Continente sconosciuto - Info sul continente non disponibili 5
SA - Sud America 3
OC - Oceania 2
Totale 1.035
Nazione #
US - Stati Uniti d'America 613
UA - Ucraina 118
CN - Cina 104
IT - Italia 49
DE - Germania 45
SE - Svezia 38
FI - Finlandia 16
FR - Francia 10
GB - Regno Unito 6
KR - Corea 4
EU - Europa 3
IN - India 3
A2 - ???statistics.table.value.countryCode.A2??? 2
AE - Emirati Arabi Uniti 2
AU - Australia 2
BE - Belgio 2
BR - Brasile 2
CA - Canada 2
SG - Singapore 2
CL - Cile 1
EE - Estonia 1
ES - Italia 1
HK - Hong Kong 1
ID - Indonesia 1
IR - Iran 1
JP - Giappone 1
ME - Montenegro 1
PH - Filippine 1
PL - Polonia 1
TW - Taiwan 1
UZ - Uzbekistan 1
Totale 1.035
Città #
Chandler 192
Jacksonville 74
Princeton 56
Nanjing 25
Dearborn 22
Ann Arbor 20
Wilmington 19
Ashburn 18
Sassari 17
New York 15
Nanchang 14
Beijing 12
Mountain View 10
Hebei 9
Cagliari 8
Shenyang 8
Boardman 7
Changsha 7
Jiaxing 7
Washington 7
Norwalk 5
Jinan 4
Milan 4
San Francisco 4
Seoul 4
Taizhou 4
Tianjin 4
Frankfurt am Main 3
Helsinki 3
San Mateo 3
Vélizy 3
Brussels 2
Kunming 2
Los Angeles 2
Monmouth Junction 2
Ningbo 2
Seattle 2
Singapore 2
Andover 1
Augusta 1
Bologna 1
Canberra 1
Central 1
Cerreto Guidi 1
Clearwater 1
Edinburgh 1
Grafing 1
Guangzhou 1
Hangzhou 1
Hanover 1
Lappeenranta 1
London 1
Los Lunas 1
Markham 1
Mumbai 1
Nuoro 1
Paris 1
Podgorica 1
Qingdao 1
Redwood City 1
Reston 1
San Juan 1
Selargius 1
Shanghai 1
Surabaya 1
Sydney 1
São Paulo 1
Taichung 1
Taiyuan 1
Tallinn 1
Tashkent 1
Tehran 1
Tokyo 1
Toronto 1
Trento 1
Woodbridge 1
Totale 640
Nome #
A rare case of lupus-like syndrome during treatment with interferon β-1a. 54
Multiple sclerosis-associated retrovirus and progressive disability of multiple sclerosis 53
An innovative training program based on virtual reality and treadmill: effects on gait of persons with multiple sclerosis 50
First evidence of the cross-training effect in multiple sclerosis 50
Virtual reality-treadmill training to improve gait in people with multiple sclerosis 49
Assessing association of comorbidities with treatment choice and persistence in MS: A real-life multicenter study 49
Personality traits predict perceived health-related quality of life in persons with multiple sclerosis 48
Inflammation, infectious triggers, and Parkinson's disease 48
Proteomic analysis of CSF in multiple sclerosis patients and controls: a study in Sardinian population 48
The Effect of Contralateral Strength Training on Muscle Weakness in People With Multiple Sclerosis: A Proof-of-Concept Case Series. 43
Treadmill-virtual reality combined training program to improve gait in multiple sclerosis individuals 40
Paresi del IX e X nervi cranici da ematoma parietale post-traumatico della carotide interna in paziente con crisi convulsiva 39
MSRV as a prognostic factor in Sardinian patients: 10-year follow-up 39
Determinants of therapy switch in multiple sclerosis treatment-naïve patients: A real-life study 36
A six-week intensive treadmill training improves walking ability in MS patients with moderate disability 35
Intensive treadmill training improves gait in moderately impaired multiple sclerosis individuals 34
Sclerosi combinata del midollo, neuropatia ottica e deterioramento cognitivo post-resezione intestinale. Ruolo patogenetico della carenza di oligoelementi? 34
Antibody response against HERV-W in patients with MOG-IgG associated disorders, multiple sclerosis and NMOSD 31
Herv-k modulates the immune response in als patients 28
Long-term trajectory of acquired demyelinating syndrome and multiple sclerosis in children 27
Natalizumab as treatment option of refractory epilepsy in multiple sclerosis. 24
HERV-W/MSRV in the CSF significantly predicts the secondary progressive MS course upon 10-years follow-up 22
Cross-sectional analysis of the humoral response after SARS-CoV-2 vaccination in Sardinian multiple sclerosis patients, a follow-up study 21
Effect of Different Disease-Modifying Therapies on Humoral Response to BNT162b2 Vaccine in Sardinian Multiple Sclerosis Patients 20
Corpus callosum volumetrics and clinical progression in early multiple sclerosis 19
Influence of psychological and social factors on self perceived health-related quality of life in patients with multiple sclerosis 18
Prolonged B-cell depletion after rituximab in AQP4-IgG-positive neuromyelitis optica spectrum disorder 17
Antihuman Endogenous Retrovirus Immune Response and Adaptive Dysfunction in Autism 14
COVID-19 Severity in Multiple Sclerosis: Putting Data Into Context 11
A multi-element psychosocial intervention for early psychosis (GET UP PIANO TRIAL) conducted in a catchment area of 10 million inhabitants: study protocol for a pragmatic cluster randomized controlled trial 9
On a 5-year-old girl with multiple sclerosis treated with natalizumab 8
Rasagiline Withdrawal Syndrome in Parkinson’s Disease 8
Signs and symptoms of COVID-19 in patients with multiple sclerosis 7
Maternal multiple sclerosis is not a risk factor for neurodevelopmental disorders in offspring 6
Detection of disability worsening in relapsing-remitting multiple sclerosis patients: a real-world roving Expanded Disability Status Scale reference analysis from the Italian Multiple Sclerosis Register 6
RNA-binding proteins in autoimmunity: From genetics to molecular biology 5
SARS-CoV-2 serology after COVID-19 in multiple sclerosis: An international cohort study 5
Tdp‐43 and herv‐k envelope‐specific immunogenic epitopes are recognized in als patients 5
The effect of air pollution on COVID-19 severity in a sample of patients with multiple sclerosis 4
The impact of PM2.5, PM10 and NO2 on Covid-19 severity in a sample of patients with multiple sclerosis: A case-control study 4
First therapy choice in newly diagnosed Multiple Sclerosis patients: A multicenter Italian study 4
Corpus callosum volumetrics and clinical progression in early multiple sclerosis 4
Risk of disease relapse, safety and tolerability of SARS-CoV-2 vaccination in patients with chronic inflammatory neuropathies 3
Cladribine vs other drugs in MS: Merging randomized trial with real-life data 2
Antibody Response to HERV-K and HERV-W Envelope Epitopes in Patients with Myasthenia Gravis 2
The role of ethnicity and native-country income in multiple sclerosis: the Italian multicentre study (MS-MigIT) 1
Multiple Sclerosis Progression and Relapse Activity in Children 1
Determinants of self-perceived quality of life in mildly disabled multiple sclerosis patients: a cross-sectional study 1
Totale 1.086
Categoria #
all - tutte 6.682
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.682


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2018/20197 0 0 0 0 0 0 0 0 0 0 0 7
2019/2020204 54 2 11 0 20 21 42 4 23 4 22 1
2020/2021170 19 1 23 0 21 4 21 1 31 23 18 8
2021/2022153 12 0 3 1 2 2 3 23 12 27 12 56
2022/2023355 28 46 6 57 43 44 1 34 55 21 11 9
2023/2024128 16 17 8 6 36 20 1 11 0 7 6 0
Totale 1.086